WallStreetZenWallStreetZen

NASDAQ: VCEL
Vericel Corp Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for VCEL

Based on 2 analysts offering 12 month price targets for Vericel Corp.
Min Forecast
$34.00+41.9%
Avg Forecast
$39.50+64.86%
Max Forecast
$45.00+87.81%

Should I buy or sell VCEL stock?

Based on 2 analysts offering ratings for Vericel Corp.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VCEL stock forecasts and price targets.

VCEL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
BTIG
Top 3%
98
Strong BuyMaintains$34.00+41.90%2022-07-18
SVB Leerink
Bottom 3%
3
BuyMaintains$45.00+87.81%2022-02-25
Anonymous
Truist Securities
Strong BuyMaintains$52.00+117.03%2021-12-21

1 of 1

Forecast return on equity

Is VCEL forecast to generate an efficient return?
Company
35.08%
Industry
18.78%
Market
118.57%
VCEL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VCEL forecast to generate an efficient return on assets?
Company
25.05%
Industry
14.1%
VCEL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VCEL earnings per share forecast

What is VCEL's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$0.23
Avg 2 year Forecast
$0.16
Avg 3 year Forecast
$0.62

VCEL revenue forecast

What is VCEL's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$177.8M+14.56%
Avg 2 year Forecast
$221.2M+42.5%
Avg 3 year Forecast
$284.5M+83.31%
VCEL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VCEL revenue growth forecast

How is VCEL forecast to perform vs Biotechnology companies and vs the US market?
Company
21.56%
Industry
23.75%
Market
8.46%
VCEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VCEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VCEL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VCEL$23.96$39.50+64.86%Strong Buy
SANA$5.93$14.67+147.34%Buy
KYMR$21.69$47.30+118.07%Buy
GOSS$12.14$18.57+52.97%Buy
FGEN$12.18$14.40+18.23%Hold

Vericel Stock Forecast FAQ

Is Vericel Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: VCEL) stock is to Strong Buy VCEL stock.

Out of 2 analysts, 1 (50%) are recommending VCEL as a Strong Buy, 1 (50%) are recommending VCEL as a Buy, 0 (0%) are recommending VCEL as a Hold, 0 (0%) are recommending VCEL as a Sell, and 0 (0%) are recommending VCEL as a Strong Sell.

If you're new to stock investing, here's how to buy Vericel stock.

What is VCEL's earnings growth forecast for 2022-2024?

(NASDAQ: VCEL) Vericel's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 8.67%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.42%.

Vericel's earnings in 2022 is -$16,450,000.On average, 4 Wall Street analysts forecast VCEL's earnings for 2022 to be -$10,850,934, with the lowest VCEL earnings forecast at -$13,681,612, and the highest VCEL earnings forecast at -$8,492,035. On average, 4 Wall Street analysts forecast VCEL's earnings for 2023 to be $7,548,476, with the lowest VCEL earnings forecast at -$1,415,339, and the highest VCEL earnings forecast at $17,927,630.

In 2024, VCEL is forecast to generate $29,250,344 in earnings, with the lowest earnings forecast at $24,060,767 and the highest earnings forecast at $33,968,141.

What is VCEL's revenue growth forecast for 2022-2024?

(NASDAQ: VCEL) Vericel's forecast annual revenue growth rate of 21.56% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 23.75%, and while it is forecast to beat the US market's average forecast revenue growth rate of 8.46%.

Vericel's revenue in 2022 is $155,217,000.On average, 2 Wall Street analysts forecast VCEL's revenue for 2022 to be $8,389,328,871, with the lowest VCEL revenue forecast at $8,388,243,777, and the highest VCEL revenue forecast at $8,390,413,964. On average, 2 Wall Street analysts forecast VCEL's revenue for 2023 to be $10,434,777,111, with the lowest VCEL revenue forecast at $10,226,203,288, and the highest VCEL revenue forecast at $10,643,350,934.

In 2024, VCEL is forecast to generate $13,423,737,654 in revenue, with the lowest revenue forecast at $13,423,737,654 and the highest revenue forecast at $13,423,737,654.

What is VCEL's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: VCEL) forecast ROA is 25.05%, which is higher than the forecast US Biotechnology industry average of 14.1%.

What is VCEL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year VCEL price target, the average VCEL price target is $39.50, with the highest VCEL stock price forecast at $45.00 and the lowest VCEL stock price forecast at $34.00.

On average, Wall Street analysts predict that Vericel's share price could reach $39.50 by Jul 18, 2023. The average Vericel stock price prediction forecasts a potential upside of 64.86% from the current VCEL share price of $23.96.

What is VCEL's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: VCEL) Vericel's current Earnings Per Share (EPS) is -$0.35. On average, analysts forecast that VCEL's EPS will be -$0.23 for 2022, with the lowest EPS forecast at -$0.29, and the highest EPS forecast at -$0.18. On average, analysts forecast that VCEL's EPS will be $0.16 for 2023, with the lowest EPS forecast at -$0.03, and the highest EPS forecast at $0.38. In 2024, VCEL's EPS is forecast to hit $0.62 (min: $0.51, max: $0.72).

What is VCEL's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: VCEL) forecast ROE is 35.08%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.